Trisalus Life Sciences, Inc. balance sheet

At the end of fiscal 2025, Trisalus Life Sciences, Inc. had total assets of $35.3m, total liabilities of $69.2m and shareholders' equity of −$33.9m. It held $20.4m in cash against $33.0m of debt: net debt of $12.6m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Trisalus Life Sciences, Inc.: balance sheet, annual
Fiscal year	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025	LTMJun 2026
Cash and equivalents	9	12	9	20	46
Receivables	2	4	5	7	6
Inventory	1	3	4	3	4
Total current assets	17	21	21	32	60
Total assets	22	25	24	35	62
Total current liabilities	32	15	10	11	11
Long-term debt	—	0	22	33	33
Total debt	1	0	22	33	33
Total liabilities	34	52	50	69	56
Shareholders' equity	−177	−27	−26	−34	7
Non-controlling interests and other (assets − liabilities − equity)	165	—	—	—	—
Net debt (negative = net cash)	−8	−12	14	13	−13
Shares outstanding	—	—	31m	—	61m

US$ millions unless shown otherwise. Fiscal quarters.

Trisalus Life Sciences, Inc.: balance sheet, quarterly
Quarter	2024 Q3Sept 2024	2024 Q4Dec 2024	2025 Q1Mar 2025	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026
Receivables	5	5	5	6	5	7	5	6
Inventory	4	4	4	4	3	3	4	4
Total current assets	24	21	25	38	33	32	68	60
Total assets	27	24	29	41	36	35	71	62
Total current liabilities	10	10	12	9	11	11	12	11
Long-term debt	22	22	32	32	33	33	33	33
Total debt	22	22	32	32	33	33	33	33
Total liabilities	48	50	63	61	63	69	58	56
Shareholders' equity	−20	−26	−34	−19	−27	−34	13	7
Shares outstanding	30m	31m	32m	38m	50m	50m	61m	61m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: KRMD vs TLSI CLPT vs TLSI SNWV vs TLSI MYO vs TLSI

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Trisalus Life Sciences, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Trisalus Life Sciences, Inc.